Hearzap Acquires Amplifon India, Surpassing Rs 230 Crore Revenue Goal

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorKavya Nair|Published at:
Hearzap Acquires Amplifon India, Surpassing Rs 230 Crore Revenue Goal
Overview

Hearzap has acquired Amplifon India, integrating approximately 240 points of sale. This strategic move, backed by 360 ONE Asset Management, is set to propel the combined entity's revenue past Rs 230 crore. The acquisition significantly expands Hearzap's national footprint, accelerating its ambition to lead India's organized hearing care sector through a blend of technology and clinical expertise.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Scaling Up with Amplifon India

Hearzap's acquisition of Amplifon India marks a strategic shift towards rapid market consolidation, accelerating its growth ambitions beyond organic expansion. The integration of approximately 240 points of sale significantly expands Hearzap's national footprint. This move is expected to propel the combined entity's revenue past Rs 230 crore, positioning Hearzap as a major player in India's organized hearing care market. Amplifon India previously generated about Rs 120 crore in annual revenue.

Market Growth and Hearzap's Strategy

India's hearing aid market is poised for substantial growth, with projections indicating a rise from approximately USD 300 million to over USD 1.4 billion by 2035. This expansion is primarily driven by India's aging population and increasing awareness of hearing health. Hearzap aims to build a dominant, domestically integrated company capable of navigating local market dynamics effectively. By combining its technology-driven platform with Amplifon India's clinical expertise and customer base, Hearzap seeks to differentiate itself from international competitors, many of whom focus solely on product sales. This strategy is crucial in addressing industry challenges such as high device costs, limited insurance coverage, and a shortage of trained audiologists, particularly outside major cities. Hearzap's digital solutions for remote diagnosis and virtual consultations are intended to improve accessibility and affordability.

Integration Hurdles and Risks

Integrating Amplifon India presents significant challenges. Amplifon's divestment stemmed from a global 'Fit4Growth' program, as the Indian operations had negatively impacted the parent group's EBITDA, generating only about €12 million (roughly Rs 110 crore) in revenue for 2025. Hearzap must demonstrate its ability to improve these operations. The high cost of hearing aids, ranging from Rs 20,000 to Rs 3 lakhs, remains a major barrier for many Indian consumers. Furthermore, a persistent shortage of qualified audiologists across India means service quality and accessibility can be inconsistent, especially in smaller towns. Hearzap's success hinges on efficiently integrating and optimizing Amplifon's network while continuing to innovate its tech solutions, a task requiring proven operational efficiency at scale.

Future Growth Targets and Investor Support

Looking ahead, Hearzap targets Rs 250 crore in revenue by the end of the current fiscal year and aims to reach nearly Rs 500 crore by FY2029. The company plans to expand its network to around 500 centers by 2027. Hearzap's investor, 360 ONE Asset Management, views the hearing health market as attractive and growing, signaling continued strategic support for Hearzap's expansion initiatives. The broader market is projected to grow at a Compound Annual Growth Rate (CAGR) of 5% to 9.6% through 2030-2035, creating a favorable environment for consolidated players that can effectively address market access and technological integration.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.